211 related articles for article (PubMed ID: 20432258)
21. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
Chen YF; Tseng CY; Wang HW; Kuo HC; Yang VW; Lee OK
Hepatology; 2012 Apr; 55(4):1193-203. PubMed ID: 22095466
[TBL] [Abstract][Full Text] [Related]
22. Stem and progenitor cell systems in liver development and regeneration.
Kamiya A; Inagaki Y
Hepatol Res; 2015 Jan; 45(1):29-37. PubMed ID: 24773763
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
24. In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins.
Liu H; Kim Y; Sharkis S; Marchionni L; Jang YY
Sci Transl Med; 2011 May; 3(82):82ra39. PubMed ID: 21562231
[TBL] [Abstract][Full Text] [Related]
25. Induced pluripotency: history, mechanisms, and applications.
Stadtfeld M; Hochedlinger K
Genes Dev; 2010 Oct; 24(20):2239-63. PubMed ID: 20952534
[TBL] [Abstract][Full Text] [Related]
26. Embryonic stem cell lines derived from human blastocysts.
Thomson JA; Itskovitz-Eldor J; Shapiro SS; Waknitz MA; Swiergiel JJ; Marshall VS; Jones JM
Science; 1998 Nov; 282(5391):1145-7. PubMed ID: 9804556
[TBL] [Abstract][Full Text] [Related]
27. Deepening the understanding of CNVs on chromosome 15q11-13 by using hiPSCs: An overview.
Giovenale AMG; Ruotolo G; Soriano AA; Turco EM; Rotundo G; Casamassa A; D'Anzi A; Vescovi AL; Rosati J
Front Cell Dev Biol; 2022; 10():1107881. PubMed ID: 36684422
[TBL] [Abstract][Full Text] [Related]
28. Identification of Subtypes of HCC Using Bioinformatics and the Hepatocyte Differentiation Model.
Cheng W; Zhang Y; Liu M
Methods Mol Biol; 2022; 2544():253-258. PubMed ID: 36125724
[TBL] [Abstract][Full Text] [Related]
29. Laminin 332-functionalized coating to regulate the behavior of keratinocytes and gingival mesenchymal stem cells to enhance implant soft tissue sealing.
Liu L; Wang J; Li Y; Liu B; Zhang W; An W; Wang Q; Xu B; Zhao L; Ma C
Regen Biomater; 2022; 9():rbac054. PubMed ID: 36072266
[TBL] [Abstract][Full Text] [Related]
30. Human-Origin iPSC-Based Recellularization of Decellularized Whole Rat Livers.
Acun A; Oganesyan R; Jaramillo M; Yarmush ML; Uygun BE
Bioengineering (Basel); 2022 May; 9(5):. PubMed ID: 35621497
[TBL] [Abstract][Full Text] [Related]
31. RNA-Based Strategies for Cell Reprogramming toward Pluripotency.
Bailly A; Milhavet O; Lemaitre JM
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214051
[TBL] [Abstract][Full Text] [Related]
32. Insights into the present and future of cartilage regeneration and joint repair.
Evenbratt H; Andreasson L; Bicknell V; Brittberg M; Mobini R; Simonsson S
Cell Regen; 2022 Feb; 11(1):3. PubMed ID: 35106664
[TBL] [Abstract][Full Text] [Related]
33. Generation of Functional Cardiomyocytes from Human Gastric Fibroblast-Derived Induced Pluripotent Stem Cells.
Wu CH; Lin HH; Wu YY; Chiu YL; Huang LY; Cheng CC; Yang CC; Tsai TN
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829794
[TBL] [Abstract][Full Text] [Related]
34. An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells.
Hsu LJ; Liu CL; Kuo ML; Shen CN; Shen CR
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680440
[TBL] [Abstract][Full Text] [Related]
35. Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research.
Wehbe Z; Ghanjati F; Flotho C
Cells; 2021 Sep; 10(9):. PubMed ID: 34571984
[TBL] [Abstract][Full Text] [Related]
36. The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review.
Zhang L; Pu K; Liu X; Bae SDW; Nguyen R; Bai S; Li Y; Qiao L
Front Med (Lausanne); 2021; 8():644594. PubMed ID: 34277651
[TBL] [Abstract][Full Text] [Related]
37. The stemness of hepatocytes is maintained by high levels of lipopolysaccharide via YAP1 activation.
Shao C; Yang X; Jing Y; Hou X; Huang Y; Zong C; Gao L; Liu W; Jiang J; Ye F; Shi J; Zhao Q; Li R; Zhang X; Wei L
Stem Cell Res Ther; 2021 Jun; 12(1):342. PubMed ID: 34112239
[TBL] [Abstract][Full Text] [Related]
38. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.
Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE
Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426
[TBL] [Abstract][Full Text] [Related]
39. Convergence of human pluripotent stem cell, organoid, and genome editing technologies.
Wang L; Ye Z; Jang YY
Exp Biol Med (Maywood); 2021 Apr; 246(7):861-875. PubMed ID: 33467883
[TBL] [Abstract][Full Text] [Related]
40. "Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy.
Rovina D; Castiglioni E; Niro F; Mallia S; Pompilio G; Gowran A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
